G
GeneCast Biotechnology
Biotech & Life Sciences · Haidian, China · Founded 2014
It is a Beijing cancer diagnosis company MoreLess
Genecast operates in the precision medicine and companion diagnostics sector, focusing on personalized treatment to extend patient life spans. Utilizing advanced technologies such as high throughput sequencing, bioinformatics, and cutting-edge translational medicine, Genecast aims to enhance cancer understanding and treatment. Their services include Next Generation Sequencing (NGS), Multiplex Immunohistochemistry (IHC), Immuno-Oncology (IO) Gene Expression Profiling, Immuno-Oncology Protein Liquid Chip, T Cell Receptor (TCR) Sequencing, DNA Methylation, and Circulating Tumor Cell (CTC) Testing. Genecast partners with pharmaceutical companies, research institutions, and clinical organizations to provide biomarker discovery, clinical trial services, companion diagnostics development, clinical research services, project and process management, and patient recruitment. The company generates revenue through service contracts with these partners, offering specialized diagnostic and research capabilities. Genecast is committed to improving the quality of life for patients by providing personalized medical guidance and innovative diagnostic solutions. Keywords: precision medicine, companion diagnostics, high throughput sequencing, bioinformatics, personalized treatment, cancer research, biomarker discovery, clinical trials, patient recruitment, translational medicine.
Company overview
GeneCast Biotechnology company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2014
- Headquarters
- Haidian, China
- Employees
- 26
- Open positions
- None listed
- Dealroom signal
- 51.5
Valuation & funding
GeneCast Biotechnology funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES EOther financing | Oct 2020 | $149M | $596M | Hillhouse Capital · CCB International · Taiping Asset Management · China Structural Reform Fund | — |
| SERIES DOther financing | Oct 2019 | $43M | $170M | TMT Investments · Matrix Partners China · Cowin Venture · CICC | — |
| SERIES COther financing | Feb 2018 | $33M | $132M | Cowin Venture · Loyal Valley Capital · Matrix Partners China | — |
| SEEDOther financing | Sep 2017 | — | — | Undisclosed | — |
| SERIES BOther financing | Feb 2017 | $18M | $72M | Tsinghua Holdings | — |
Growth signals
GeneCast Biotechnology website traffic
Latest recorded traffic for GeneCast Biotechnology is 1.2K monthly website visits, up 44.6% over the last three months. GeneCast Biotechnology's team grew 8.3% over the past year.
Comparisons
GeneCast Biotechnology compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
 Blueprint GeneticsUses Next Generation Sequencing (NGS) to perform diagnostics on genetic diseases |
Espoo, Finland | Operational | 220 | $36M | $62M |
 Probably GeneticProbably Genetic helps rare genetic disease patients get diagnosed |
San Francisco, United States | Operational | |||
 23MofangGenetics testing and analyzing Startup Based In China |
Chengdu, China | Operational | |||
 AnchorDxAnchorDx is a precision medicine firm |
Guangzhou, China | Operational | |||
 GeneAdviserOur mission is to make genetic testing for rare diseases more accessible to clinicians around the world |
Cambridge, United Kingdom | Operational | |||
 PrevnosBiotechnology company operating within the in vitro diagnostics sector |
Jersey City, United States | Operational | |||
 PierianDxEnables clinical labs to deliver patient-specific diagnosis and treatments |
St. Louis, United States | Acquired | |||
 Shield BioFighting antibiotic resistance with genomics |
Santa Clara, United States | Closed |
Talent graph
GeneCast Biotechnology's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where GeneCast Biotechnology has talent and traffic
team presence
In the news
Latest news about GeneCast Biotechnology
Recent press, funding announcements, and product moves mentioning GeneCast Biotechnology — open to read from the original sources.
Market sentiment
What the market is saying about GeneCast Biotechnology
An AI-synthesized read of the highest-engagement posts about GeneCast Biotechnology on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See GeneCast Biotechnology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.